Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DMPE-mPEG(2000) is a PEGylated derivative of 1,2-dimyristoyl-sn-glycero-3-PE (1,2-DMPE; Item No. 15090). It has been used in the formation of nanostructured lipid carriers (NLCs) and liposomes for the delivery of small molecules in vitro and in vivo.1,2 NLCs containing DMPE-mPEG(2000) have been used for ocular delivery of ciprofloxacin (Item No. 14286) in rabbits.1 Liposomes containing DMPE-mPEG(2000) and encapsulating cabazitaxel (Item No. 22262) decrease tumor volume and weight in a primary 4T1 murine breast cancer model.2 These liposomes also decrease the number of pulmonary metastatic nodules and increase survival in a metastatic 4T1 murine breast cancer model.
WARNING This product is not for human or veterinary use.
1. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol. Int. J. Pharm. 529(1-2), 32-43 (2017).
2. Deciphering apolipoprotein A4 in the protein corona of ligand-